The import of pharmaceutical products to South Korea has shown a general upward trend from 2013 to 2023, with fluctuating year-on-year growth rates. The value stood at 7.629 billion US Dollars in 2023. Notable variations include significant increases in 2014 (14.06%) and 2018 (15.93%), and a decrease in 2022 (-5.75%). The Compound Annual Growth Rate (CAGR) over the last five years was 3.29%, indicating moderate growth.
Forecasted data from 2024 to 2028 shows a steady increase in pharmaceutical imports, with the value expected to reach 8.8712 billion US Dollars by 2028. The forecasted 5-year CAGR is 2.26%, suggesting a stable yet slower growth rate compared to historical trends.
Future trends to watch for include innovations in pharmaceutical technology, regulatory changes, and potential impacts of global health scenarios which could significantly influence South Korea's import dynamics.
Latest reports
US Vaccine Market Report- Q1 2025
The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...
China Vaccine Market Report- Q1 2025
The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...
Japan Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...
Germany Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...
India Vaccine Market Report- Q4 2024
The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...
UK Vaccine Market Report- Q4 2024
The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...
France Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...
Canada Vaccine Market Report- Q4 2024
The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...
Brazil Vaccine Market Report- Q4 2024
The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...
Italy Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...
